Showing results (331-340 of 463) with videos related to

Sort By:
Pageof 47
European Journal of Clinical Pharmacology|January 1, 1994
Azithromycin does not alter the effects of oral midazolam on human performanceM J Mattila, J Vanakoski, J J Idänpään-Heikkilä
Leukemia|January 1, 1987
Bone marrow cytogenetics: the lineage of dividing cells changes during the first few hours in cultureM Keinänen, S Knuutila, C D Bloomfield, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1997
Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implicationsV J Anttila, E Elonen, S Nordling, et al.
Diabetologia|August 5, 2003
Gemfibrozil considerably increases the plasma concentrations of rosiglitazoneM Niemi, J T Backman, M Granfors, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2000
Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humansJ S Wang, J T Backman, P Taavitsainen, et al.
British Journal of Clinical Pharmacology|September 30, 2000
Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylationS Palovaara, K T Kivistö, P Tapanainen, et al.
British Journal of Clinical Pharmacology|March 1, 1994
Dose of midazolam should be reduced during diltiazem and verapamil treatmentsJ T Backman, K T Olkkola, K Aranko, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 17, 2001
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9X Wen, J S Wang, J T Backman, et al.
Pageof 47